HIGHLIGHTS
- who: Laurence Legros from the (UNIVERSITY) have published the article: Progressive erythrocytosis under lenvatinib treatment in patients with advanced hepatocellular carcinoma, in the Journal: (JOURNAL) of December/15,/2021
- what: The authors report what is to the knowledge the first series demonstrating the occurrence of early and very frequent erythrocytosis in HCC patients under lenvatinib, with a potential risk of thromboembolic complications. In case of erythrocytosis, the authors propose to initiate thromboprophylaxis (i.e., low-dose ASA).
SUMMARY
For palliative treatments, a few systemic therapies have been shown to provide survival . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.